RT Book, Section
A1 Kodera, Yasuhiro
A1 Sasako, Mitsuru
A2 Morita, Shane Y.
A2 Balch, Charles M.
A2 Klimberg, V. Suzanne
A2 Pawlik, Timothy M.
A2 Posner, Mitchell C.
A2 Tanabe, Kenneth K.
SR Print(0)
ID 1145761684
T1 Multimodality Therapy of Gastric Cancer: Eastern Experience
T2 Textbook of Complex General Surgical Oncology
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071793315
LK hemonc.mhmedical.com/content.aspx?aid=1145761684
RD 2024/04/20
AB Several  bodies  of  evidence  both  from  the  West  and  the  East  currently  recommend  that  some  form  of  adjuvant  therapy  should  be  delivered  in  addition  to  surgery  in  patients  with  potentially  curable  advanced  gastric  cancer.  Progress  in  surgical  technique  to  dissect  cancer  with  wide  resection  margin  may  have  reached  a  plateau,1  and  development  of  perioperative  adjuvant  therapy  is  the  only  way  to  improve  the  outcome.  This  chapter  describes  the  history  and  recent  advances  in  the  multimodality  treatment  in  the  Far  East  where  the  incidence  of  this  disease  remains  high.